Oxaltin
Brand Name: Oxaltin
Generic Name: Oxaliplatin
Active
Registration Number
DR-XY47591
Dosage Form
Concentrate Solution for Intravenous Injection
Issuance Date
December 28, 2022
Expiry Date
December 9, 2026
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength5 mg/mL (50 mg/10 mL and 100 mg/20 mL)
PackagingUSP Type I clear and colorless glass vial x 10 mL and
20 mL (Box of 1's)
Classification
C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antineoplastic
A
Application
Initial (correction)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
OxaliplatinActive
Monograph: Oxaliplatin